Virtu Financial LLC Galera Therapeutics, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$0.09 - $0.27 $3,976 - $11,929	44,185 Added 359.17%	56,487 $8,000
Q3 2023 Nov 14, 2023	SELL	$0.17 - $3.0 $1,993 - $35,184	-11,728 Reduced 48.81%	12,302 $2,000
Q2 2023 Jul 27, 2023	BUY	$2.5 - $3.42 $9,587 - $13,115	3,835 Added 18.99%	24,030 $75,000
Q1 2023 May 01, 2023	BUY	$1.48 - $2.68 $29,888 - $54,122	20,195 New	20,195 $52,000
Q2 2022 Aug 09, 2022	BUY	$1.24 - $2.39 $2,517 - $4,851	2,030 Added 16.29%	14,491 $19,000
Q1 2022 May 17, 2022	BUY	$2.01 - $4.19 $25,046 - $52,211	12,461 New	12,461 $30,000

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.07M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.